Liver fluke isolates: A question of provenance

Veterinary Parasitology

Volumn 176, Issue 1, 2011, Pages 1-8

  Fairweather, I ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Fasciola hepatica; Fluke provenance; Liver fluke; Published articles

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; ANTHELMINTIC AGENT; ANTITREMATODAL AGENT; ARTEMETHER; ARTEMISIN DERIVATIVE; ARTESUNATE; CLORSULON; CLOSANTEL; COMPOUND ALPHA; FASCIOLICIDE; GENISTEIN; IVERMECTIN; LEVAMISOLE; LUXABENDAZOLE; NITROXINIL; OXYCLOZANIDE; OZ 78; RAFOXANIDE; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIVITY; FASCIOLA HEPATICA; FASCIOLIASIS; MEDICAL LITERATURE; NONHUMAN; PARASITE ISOLATION; PARASITE LOAD; PHYSICAL RESISTANCE; REVIEW; STRAIN DIFFERENCE; TREMATODE LIFE CYCLE STAGE;

ANIMALS; ANTHELMINTICS; FASCIOLA HEPATICA;

FASCIOLA HEPATICA; NEMATODA;

EID: 79951578156     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2010.12.011     Document Type: Review

References (71)

1. Alvarez L.I., Solana H.D., Mottier M.L., Virkel G.L., Fairweather I., Lanusse C.E. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes. Parasitology 2005, 131:501-510.
2. Alvarez L., Moreno G., Moreno L., Ceballos L., Shaw L., Fairweather I., Lanusse C. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs. Vet. Parasitol. 2009, 164:211-216.
3. Alvarez-Sánchez M.A., Mainar-Jaime R.C., Pérez-García J., Rojo-Vázquez F.A. Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain. Vet. Rec. 2006, 159:424-425.
4. Anon Northern Ireland disease surveillance, January to March. Vet. Rec. 2006, 159:615-618.
5. Anon Increase in chronic fasciolosis in sheep in Scotland. Vet. Rec. 2008, 162:199-202.
6. Anon Increase in chronic fasciolosis in sheep in Scotland. Vet. Rec. 2008, 162:537-540.
7. Anon Northern Ireland disease surveillance, January to March. Vet. Rec. 2008, 163:135-138.
8. Anon Incidents of coccidiosis and fasciolosis common in Scottish cattle and sheep. Vet. Rec. 2009, 164:483-486.
9. Boray J.C. Drug resistance in Fasciola hepatica. Resistance of Parasites to Antiparasitic Drugs 1990, 51-60. MSD AGVET, Rahway, NJ. J.C. Boray, P.J. Martin, R.T. Roush (Eds.).
10. Boray J.C., De Bono D. Drug resistance in Fasciola hepatica. Advances in Veterinary Science 1989, 166-169. The Australian Veterinary Association, Artarmon, Australia. P.M. Outteridge, R.B. Richards (Eds.).
11. Boray J.C., Sluyter V., Campbell N.J., McKinnon A. Resistance of immature and adult Fasciola hepatica to triclabendazole in the field. Proceedings of the 16th International Conference on World Association for the Advancement of Veterinary Parasitology (WAAVP) 1997, 10.
12. Borgsteede F.H.M., Moll L., Vellema P., Gaasenbeek C.P.H. Lack of reversion in triclabendazole-resistant Fasciola hepatica. Vet. Rec. 2005, 156:350-351.
13. Buchanan J.F., Fairweather I., Brennan G.P., Trudgett A., Hoey E.M. Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole (" Valbazen" ). Parasitology 2003, 126:141-153.
14. Coles G.C., Stafford K.A. Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica. Vet. Rec. 2001, 148:723-724.
15. Coles G.C., Rhodes A.C., Stafford K.A. Activity of closantel against adult triclabendazole-resistant Fasciola hepatica. Vet. Rec. 2000, 146:504.
16. Devine C., Brennan G.P., Lanusse C.E., Alvarez L.I., Trudgett A., Hoey E., Fairweather I. Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica. Parasitology 2009, 136:183-192.
17. Devine C., Brennan G.P., Lanusse C.E., Alvarez L.I., Trudgett A., Hoey E., Fairweather I. Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole. Parasitology 2010, 137:871-880.
18. Devine C., Brennan G.P., Lanusse C.E., Alvarez L.I., Trudgett A., Hoey E., Fairweather I. Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica. Parasitol. Res. 2010, 106:1351-1363.
19. Devine C., Brennan G.P., Lanusse C.E., Alvarez L.I., Trudgett A., Hoey E., Fairweather I. Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole. Parasitol. Res. 2010, 107:337-353.
20. Devine C., Brennan G.P., Lanusse C.E., Alvarez L.I., Trudgett A., Hoey E., Fairweather I. Piperonyl butoxide enhance triclabendazole action against triclabendazole-resistant Fasciola hepatica. Parasitology 2011, 138:224-236.
21. Devine, C., Brennan, G.P., Lanusse, C.E., Alvarez, L.I., Trudgett, A., Hoey, E., Fairweather, I., Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole, Vet. Parasitol., in press. doi:10.1016/j.vetpar.2010.12.002.
22. Flanagan A.M., Edgar H.W.J., Forster F., Gordon A., Hanna R.E.B., McConville M., Brennan G.P., Fairweather I. Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica. Vet. Parasitol. 2011, 176:34-42.
23. Flanagan, A., Edgar, H.W.J., Gordon, A., Hanna, R.E.B., Brennan, G.P., Fairweather, I., Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep, Vet. Parasitol., in press. doi:10.1016/j.vetpar.2010.10.057.
24. Fletcher H.L., Hoey E.M., Orr N., Trudgett A., Fairweather I., Robinson M.W. The occurrence and significance of triploidy in the liver fluke, Fasciola hepatica. Parasitology 2004, 128:69-72.
25. Gaasenbeek C.P.H., Moll L., Cornelissen J.B.W.J., Vellema P., Borgsteede F.H.M. An experimental study on triclabendazole resistance of Fasciola hepatica in sheep. Vet. Parasitol. 2001, 95:37-43.
26. Halferty L., Brennan G.P., Hanna R.E.B., Edgar H.W., Meaney M., McConville M., Trudgett A., Hoey L., Fairweather I. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole. Vet. Parasitol. 2008, 155:49-58.
27. Halferty L., Brennan G.P., Trudgett A., Hoey L., Fairweather I. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica. Vet. Parasitol. 2009, 159:126-138.
28. Halferty L., O'Neill J.F., Brennan G.P., Keiser J., Fairweather I. Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke. Parasitology 2009, 136:1325-1337.
29. Hanna R.E.B., Edgar H., Moffett D., McConnell S., Fairweather I., Brennan G.P., Trudgett A., Hoey E.M., Cromie L., Taylor S.M., Daniel R. Fasciola hepatica: histology of the testis in egg-producing adults of several laboratory-maintained isolates grown to maturity n cattle and sheep and in flukes from naturally infected hosts. Vet. Parasitol. 2008, 157:222-234.
30. Hanna R.E.B., Edgar H.W.J., McConnell S., Toner E., McConville M., Brennan G.P., Devine C., Flanagan A., Halferty L., Meaney M., Shaw L., Moffett D., McCoy M., Fairweather I. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes collected from experimentally-infected sheep one to four days after treatment with TCBZ and the related benzimidazole derivative, Compound Alpha. Vet. Parasitol. 2010, 168:240-254.
31. Hutchinson G.W., Dawson K., Fitzgibbon C.C., Martin P.J. Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle. Vet. Parasitol. 2009, 162:278-284.
32. Keiser J., Morson G. Fasciola hepatica: tegumental alterations in adult flukes following in vitro administration of artesunate and artemether. Exp. Parasitol. 2008, 118:228-237.
33. Keiser J., Morson G. Fasciola hepatica: surface tegumental responses to in vitro and in vivo treatment with the experimental fasciolicide OZ78. Exp. Parasitol. 2008, 119:87-93.
34. Keiser J., Utzinger J., Tanner M., Dong Y., Vennerstrom J.L. The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica. J. Antimicrob. Chemother. 2006, 58:1193-1197.
35. Keiser J., Shu-Hua X., Tanner M., Utzinger J. Artesunate and artemether are effective fasciolicides in the rat model and in vitro. J. Antimicrob. Chemother. 2006, 57:1139-1145.
36. Keiser J., Utzinger J., Vennerstrom J.L., Dong Y., Brennan G.P., Fairweather I. Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica. Trans. Roy. Soc. Trop. Med. Hyg. 2007, 101:1219-1222.
37. Martínez-Valladares M., del Rosario Famularo M., Fernández-Pato N., Castañón-Ordóñez L., Cordero-Pérez C., Rojo-Vázquez F.A. Efficacy of nitroxynil against Fasciola hepatica resistant to triclabendazole in a naturally infected sheep flock. Parasitol. Res. 2010, 107:1205-1211.
38. McConville M., Brennan G.P., McCoy M., Castillo R., Hernández-Campos A., Fairweather I. Adult triclabendazole-resistant Fasciola hepatica: surface and sub-surface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. Parasitology 2006, 133:195-208.
39. McConville M., Brennan G.P., McCoy M., Castillo R., Hernandez-Campos A., Ibarra F., Fairweather I. Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. Parasitol. Res. 2007, 100:365-377.
40. McConville M., Brennan G.P., Flanagan A., Edgar H.W.J., McCoy M., Castillo R., Hernández-Campos A., Fairweather I. Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha. Vet. Parasitol. 2008, 153:52-64.
41. McConville M., Brennan G.P., Flanagan A., Edgar H.W.J., Hanna R.E.B., McCoy M., Gordon A.W., Castillo R., Hernández-Campos A., Fairweather I. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica. Vet. Parasitol. 2009, 162:75-88.
42. McConville M., Brennan G.P., Flanagan A., Hanna R.E.B., Edgar H.W.J., Castillo R., Hernández-Campos A., Fairweather I. Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha. Parasitol. Res. 2009, 105:757-767.
43. McConville M., Brennan G.P., Flanagan A., Edgar H.W.J., Castillo R., Hernández-Campos A., Fairweather I. Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha. Parasitology 2009, 136:665-680.
44. McConville M., Hanna R.E.B., Brennan G.P., McCoy M., Edgar H.W.J., McConnell S., Castillo R., Hernández-Campos A., Fairweather I. Fasciola hepatica: disruption of spermatogenesis by the fasciolicide compound alpha. Parasitol. Res. 2010, 106:311-323.
45. McCoy M.A., Fairweather I., Brennan G.P., Kenny J.M., Ellison S., Forbes A.B. The efficacy of nitroxynil and triclabendazole administered synchronously against juvenile triclabedazole-resistant Fasciola hepatica in sheep. Res. Vet. Sci. 2005, 78:33.
46. McKinstry B., Fairweather I., Brennan G.P., Forbes A.B. Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (" Trodax" ). Parasitol. Res. 2003, 91:251-263.
47. McKinstry B., Brennan G.P., Halferty L., Forbes A.B., Fairweather I. Ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo and in vitro drug treatment with nitroxynil (Trodax). Parasitol. Res. 2007, 101:929-941.
48. McKinstry B., Halferty L., Brennan G.P., Fairweather I. Morphological response of triclabendazole-susceptible and triclabendazole-resistant isolates of Fasciola hepatica to treatment in vitro with nitroxynil (Trodax). Parasitol. Res. 2009, 104:645-655.
49. Meaney M., Fairweather I., Brennan G.P., McDowell L.S.L., Forbes A.B. Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes. Parasitol. Res. 2003, 91:238-250.
50. Meaney M., Fairweather I., Brennan G.P., Forbes A.B. Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon. Parasitol. Res. 2004, 92:232-241.
51. Meaney M., Haughey S., Brennan G.P., Fairweather I. A scanning electron microscope study on the route of entry of clorsulon into the liver fluke Fasciola hepatica. Parasitol. Res. 2005, 95:117-128. 96, 189-198.
52. Meaney M., Haughey S., Brennan G.P., Fairweather I. Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica. Parasitol. Res. 2005, 95:201-212.
53. Meaney M., Allister J., McKinstry B., McLaughlin K., Brennan G.P., Forbes A.B., Fairweather I. Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke. Parasitol. Res. 2006, 99:609-621.
54. Meaney M., Allister J., McKinstry B., McLaughlin K., Brennan G.P., Forbes A.B., Fairweather I. Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke. Parasitol. Res. 2007, 100:1091-1104.
55. Miller C.M.D., Howell M.J., Boray J.C. Glutathione S-transferases as markers of salicylanilide resistance in isolates of Fasciola hepatica. Int. J. Parasitol. 1994, 24:533-542.
56. Moll L., Gaasenbeek C.P.H., Vellema P., Borgsteede F.H.M. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The Netherlands. Vet. Parasitol. 2000, 91:153-158.
57. Mooney L., Good B., Hanrahan J.P., Mulcahy G., de Waal T. The comparative efficacy of four anthelmintics against a natural acquired Fasciola hepatica infection in hill sheep flock in the west of Ireland. Vet. Parasitol. 2009, 164:201-205.
58. Mottier L., Alvarez L., Fairweather I., Lanusse C. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect. J. Parasitol. 2006, 92:1355-1360.
59. O'Neill J.F., Johnston R.C., Halferty L., Brennan G.P., Keiser j., Fairweather I. Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model. J. Helminthol. 2009, 83:151-163.
60. Robinson M.W., Trudgett A., Hoey E.M., Fairweather I. Triclabendazole-resistant Fasciola hepatica: β-tubulin and response to in vitro treatment with triclabendazole. Parasitology 2002, 124:325-338.
61. Robinson M.W., Lawson J., Trudgett A., Hoey L., Fairweather I. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitol. Res. 2004, 92:205-210.
62. Ryan L.A., Hoey E., Trudgett A., Fairweather I., Fuchs M., Robinson M.W., Chambers E., Timson D., Ryan E., Fetwell T., Ivens A., Bentley G., Johnston D. Fasciola hepatica expresses multiple α- and β-tubulin isotypes. Mol. Biochem. Parasitol. 2008, 159:73-78.
63. Sargent R.M., Chambers M., Elliott T. Seasonal differences in the efficacy of pour-on formulations of triclabendazole and ivermectin or abamectin against late immature liver fluke (Fasciola hepatica) in cattle. Vet. Parasitol. 2009, 161:133-137.
64. Toner E., Brennan G.P., Wells K., McGeown J.G., Fairweather I. Physiological and morphological effects of genistein against the liver fluke, Fasciola hepatica. Parasitology 2008, 135:1189-1203.
65. Toner E., McConvery F., Brennan G.P., Meaney M., Fairweather I. A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica. Parasitology 2009, 136:523-535.
66. Toner E., Brennan G.P., McConvery F., Meaney M., Fairweather I. A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica. Parasitology 2010, 137:855-870.
67. Toner E., Brennan G.P., Hanna R.E.B., Edgar H.W.J., Fairweather I. Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host. Vet. Parasitol. 2010, 172:238-248.
68. Toner E., Brennan G.P., Hanna R.E.B., Edgar H.W.J., Fairweather I. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host. Vet. Parasitol. 2010, 174:218-227.
69. Toner, E., Brennan, G.P., Hanna, R.E.B., Edgar, H.W.J., Fairweather, I., Disruption of egg formation by Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host, Vet. Parasitol., in press. doi:10.1016/j.vetpar.2010.11.032.
70. Walker S.M., McKinstry B., Boray J.C., Brennan G.P., Trudgett A., Hoey E.M., Fletcher H., Fairweather I. Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro. Parasitol. Res. 2004, 94:427-438.
71. Walker S.M., Hoey E., Fletcher H., Brennan G.P., Fairweather I., Trudgett A. Stage-specific differences in fecundity over the life-cycle of two characterized isolates of the live fluke Fasciola hepatica. Parasitology 2006, 133:209-216.